Growth Metrics

HCA Healthcare (HCA) EBIT (2016 - 2026)

HCA Healthcare (HCA) has disclosed EBIT for 17 consecutive years, with -$566.0 million as the latest value for Q1 2026.

  • For Q1 2026, EBIT rose 62.71% year-over-year to -$566.0 million; the TTM value through Mar 2026 reached -$7.6 billion, up 19.89%, while the annual FY2025 figure was $2.1 billion, 15.36% up from the prior year.
  • EBIT hit -$566.0 million in Q1 2026 for HCA Healthcare, up from -$4.8 billion in the prior quarter.
  • Across five years, EBIT topped out at -$424.0 million in Q1 2024 and bottomed at -$4.8 billion in Q4 2025.
  • Average EBIT over 5 years is -$1.6 billion, with a median of -$972.0 million recorded in 2023.
  • Year-over-year, EBIT crashed 272.21% in 2022 and then soared 69.05% in 2025.
  • HCA Healthcare's EBIT stood at -$911.0 million in 2022, then tumbled by 252.58% to -$3.2 billion in 2023, then crashed by 47.07% to -$4.7 billion in 2024, then decreased by 2.12% to -$4.8 billion in 2025, then skyrocketed by 88.27% to -$566.0 million in 2026.
  • According to Business Quant data, EBIT over the past three periods came in at -$566.0 million, -$4.8 billion, and -$1.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.